There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 20, Arrowhead Pharmaceuticals Inc's Director, Hongbo Lu, invested $82,990.00 into 3,000 shares of ARWR, for a cost per share of $27.66..